Akshay Vaishnaw
Director/Board Member bij SCHOLAR ROCK HOLDING CORPORATION
Vermogen: 4 M $ op 31-03-2024
Profiel
Dr. Akshay K. Vaishnaw is Onafhankelijk Bestuurder bij Scholar Rock Holding Corp., Onafhankelijk Bestuurder bij Editas Medicine, Inc., President-Research & Development bij Alnylam Pharmaceuticals, Inc. en Lid van The Royal College of Physicians. Hij zetelt in de Raad van Bestuur van Scholar Rock Holding Corp., Scholar Rock, Inc. en Editas Medicine, Inc. Dr. Vaishnaw was voorheen werkzaam als Senior Director-Translational Medicine bij Biogen Idec, Inc. Hij was ook lid van de raad van bestuur van Visterra, Inc. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Cardiff, een doctoraatsdiploma aan de Cardiff University School of Medicine en een doctoraatsdiploma aan de Universiteit van Londen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-01-2024 | 23 289 ( 0.02% ) | 3 M $ | 31-03-2024 | |
| 21-06-2023 | 9 455 ( 0.01% ) | 167 921 $ | 31-03-2024 | |
EDITAS MEDICINE, INC.
-.--% | 01-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Akshay Vaishnaw
| Bedrijven | Functie | Begin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02-10-2023 |
| EDITAS MEDICINE, INC. | Director/Board Member | 28-07-2016 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 21-05-2019 |
| The Royal College of Physicians | Corporate Officer/Principal | 07-07-2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 01-05-2019 |
Eerdere bekende functies van Akshay Vaishnaw
| Bedrijven | Functie | Einde |
|---|---|---|
| VISTERRA INC | Director/Board Member | 01-07-2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Akshay Vaishnaw
| University of London | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
